The FDA has approved Zevaskyn, the first gene-modified cellular therapy for treating wounds in patients with recessive dystrophic epidermolysis bullosis, a rare genetic skin disorder. Made by Abeona ...

The use of an investigational topical BRAF-inhibiting gel appeared to be effective in treating acneiform rash in patients ...

A TikTok user (@onenevertwhoo_one) shared his unfortunate experience of contracting molluscum contagiosum, a viral skin infection, allegedly from unwashed thrifted clothes. The infection, ...

We all dream of luscious, thick, Rapunzel-level hair, but real talk: no magical potion is going to give you instant results ...

Topical BRAF inhibitor LUT014 gel significantly reduces acneiform rash from anti-EGFR therapies in patients with colorectal ...

You can improve your skin texture through a combination of natural self-care methods, skincare products, and treatment ...

The U.S. Food and Drug Administration has approved Abeona Therapeutics' Zevaskyn (prademagene zamikeracel) for patients with ...

Skinfix recently brought the first exosome skin-care moisturizer to market, a “vegan growth factor” peptide moisturizer ...

Barely a year after the U.S. FDA shackled Abeona Therapeutics Inc.’s cell-based gene therapy with a complete response letter, the agency has approved it for treating a rare and genetic skin disease.

Patients with the debilitating dermatologic condition are born with COL7A1 mutations in both gene copies, affecting the ...

Shares of Abeona Therapeutics Inc. (ABEO) were in the spotlight on Tuesday afternoon after it announced that the U.S. Food ...